Topical treatments for athlete's foot
Referencias
Additional references
Auger P, Marquis G, Joly J, Attye A. Epidemiology of tinea pedis in marathon runners: prevalence of occult athlete's foot. Mycoses 1993;36(1‐2):35‐41. [MEDLINE: 8316260]
Baker SJ, Zhang YK, Akama T, Lau A, Zhou H, Hernandez V, et al. Discovery of a new boron‐containing antifungal agent, 5‐fluoro‐1,3‐dihydro‐1‐hydroxy‐2,1‐ benzoxaborole (AN2690), for the potential treatment of onychomycosis. Journal of Medicinal Chemistry 2006;49(15):4447‐50. [MEDLINE: 16854048]
Bell‐Syer SEM, Khan SM, Torgerson DJ. Oral treatments for fungal infections of the skin of the foot. Cochrane Database of Systematic Reviews 2012, Issue 10. [DOI: 10.1002/14651858.CD003584.pub2]
Borgers M. Mechanism of action of antifungal drugs, with special reference to the imidazole derivatives. Clinical Infectious Diseases 1980;2(4):520‐34. [MEDLINE: 7003674]
Djeridane A, Djeridane Y, Ammar‐Khodja A. A clinicomycological study of fungal foot infections among Algerian military personnel. Clinical & Experimental Dermatology 2007;32(1):60‐3. [MEDLINE: 17305907]
Field LA, Adams BB. Tinea Pedia in Athletes. International Journal of Dermatology 2008;47(5):485‐92. [MEDLINE: 18412868]
Gamble C, Hollis S. Uncertainty method improved on best‐worst case analysis in a binary meta‐analysis. Journal of Clinical Epidemiology 2005;58(6):579‐88. [MEDLINE: 15878471]
Geweely NS. Antifungal activity of ozonized olive oil (Oleozone). International Journal of Agriculture & Biology 2006;8(5):670‐5.
Gupta AK, Cooper EA. Update in Antifungal Therapy of Dermatophytosis. Mycopathologia 2008;166(5‐6):353‐67. [MEDLINE: 18478357]
Hammer KA, Carson CF, Riley TV, Report for the Rural Industries Research and Development Corporation. Antifungal activityof tea tree oil: Activity against yeasts, dermatophytes and other filamentous fungi 2003. https://rirdc.infoservices.com.au/items/03‐020 (accessed 26 November 2013). [ISBN 0‐642‐58588‐1]
Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses 2008;51(4):2‐15. [MEDLINE: 18783559]
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Hsu AR, Hsu JW. Topical Review: Skin Infections in the Foot and Ankle Patient. Foot & Ankle International 2012;33(7):612‐9. [MEDLINE: 22835400]
Joly V, Bolard J, Yeni P. In vitro models for studying toxicity of antifungal agents. Antimicrobial Agents & Chemotherapy 1992;36(9):1799–804. [MEDLINE: 1416870]
Macura AB. Dermatophytes Infections. International Journal of Dermatology 1993;32(5):313‐23. [MEDLINE: 8505155]
Male O. The Significance of Mycology in Medicine. In: Hawksworth DL editor(s). Frontiers in Mycology. Wallingford: CAB International, 1990:131‐156.
McLain N, Ascanio R, Baker C, Strohaver RA, Dolan JW. Undecylenic acid inhibits morphogenesis of Candida albicans. Antimicrobial Agents & Chemotherapy 2000;44(10):2873‐75. [MEDLINE: 10991877]
Nelson MM, Martin AG, Hefferman MP. Superficial Fungal Infections: Dermatophytosis, Onychomytosis, Tinea Nigra, Piedra. In: Fitzpatrick TB editor(s). Dermatology in General Medicine. 6th Edition. New York: McGraw‐Hill, 2003:1989‐2005.
Nweze EI. Dermatophytosis in Western Africa: A Review. Pakistan Journal of Biological Sciences 2010;13(13):649‐56. [MEDLINE: 21717868]
Panackal AA, Halpern EF, Watson AJ. Cutaneous fungal infections in the United States: Analysis of the National Ambulatory Medical Care Survey (NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS), 1995‐2004. International Journal of Dermatology 2009;48(7):704‐12. [MEDLINE: 19570075]
Rinaldi MG. Dermatophytosis: Epidemiological and microbial update. Journal of the American Academy of Dermatology 2000;43(5 Suppl):s120‐4. [MEDLINE: 11044287]
Roberts DT. Prevalence of dermatophyte onychomycosis in the United Kingdom: results of an onmibus survey. British Journal of Dermatology 1992;126(Suppl 39):23‐7. [MEDLINE: 1531924]
Rotta I, Sanchez A, Gonçalves PR, Otuki MF, Correr CJ. Efficacy and safety of topical antifungals in the treatment of dermatomycosis: a systematic review. British Journal of Dermatology 2012;166(5):927‐33. [MEDLINE: 22233283]
Ryder NS, Dupont MC. Inhibition of squalene epoxidase by allylamine antimycotic compounds: A comparative study of the fungal and mammalian enzymes. Biochemistry Journal 1985;230(3):765‐70. [MEDLINE: 3877503]
Vena GA, Chieco P, Posa F, Garafolo A, Bosco A, Cassano N. Epidemiology of dermatophytoses:retrospective analysis from 2005 to 2010 and comparison with previous data from 1975. New Microbiologica 2012;35(2):207‐13. [MEDLINE: 22707134]
White IR, Carpenter J, Evans S, Schroter S. Eliciting and using expert opinions about dropout bias in randomized controlled trials. Clinical Trials 2007;4(2):125‐39. [MEDLINE: 17456512]
